Fluvoxamine EP Impurity C CAS 259526-43-7
| CAS No. | 259526-43-7 |
| Molecular Formula | C19H25F3N2O6 |
| Molecular Weight | 434.41 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Based on its molecular formula C19H25F3N2O6, Fluvoxamine EP Impurity C contains a flavonoid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 434.41 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
CATO supplies Fluvoxamine EP Impurity C (CAS 259526-43-7), a pharmacopoeial impurity reference standard (molecular formula C19H25F3N2O6, MW 434.41 g/mol) used for the identification and quantification of trace impurities in APIs.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
As a certified reference material (CRM), Fluvoxamine EP Impurity C meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
Physical & Chemical Properties
| Molecular Formula | C19H25F3N2O6 |
| Molecular Weight | 434.41 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | >95% |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 7.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2025 |
| Halogen Content | F-containing |
| Nitrogen Atoms | 2 |
Related Fluvoxamine Standards
- Fluvoxamine impurity 48 (CAS CATO-C4X-195148)
- Fluvoxamine impurity 47 (CAS CATO-C4X-195147)
- Fluvoxamine Impurity 24 (CAS 1076198-14-5)
- Fluvoxamine Impurity 30 (CAS CATO-C4X-195130)
- Fluvoxamine impurity 139 (CAS CATO-C4X-195139)
- Fluvoxamine impurity 49 (CAS CATO-C4X-195149)
- Fluvoxamine Impurity 37 (CAS CATO-C4X-195137)
- Fluvoxamine Impurity 155 (CAS CATO-C4X-195155)
Recommended Standards
- 9-(4-Bromophenyl)-3,6-di-tert-butyl-9H-carbazole (CAS 601454-33-5)
- Ponatinib Impurity 33 (CAS CATO-C4X-226933)
- 9-(2-Bromophenyl)-3,6-di-tert-butyl-9H-carbazole (CAS 1399743-51-1)
- 1,3-Dimethyl 5,5-dicyano-4-(4-fluorophenyl)-2-hydroxy-6-phenylcyclohex-1-ene-1,3-dicarboxylate (CAS 1212220-50-2)
- Travoprost Impurity 53 (CAS CATO-C4X-192553)
- Nintedanib Impurity 160 (CAS 7207-35-4)
- Phenylephrine Impurity 33 (CAS CATO-C4X-146733)
- 2-[1-Butyl-3-(4-Fluorophenyl)-2-Methylindol-5-Yl]Oxy-2-Methylpropanoic Acid (CAS 76469-04-0)
- 5-Chloro-1-methyl-1H-benzimidazole (CAS 10394-36-2)
- 4’-Bromo-2’-methylacetanilide (CAS 24106-05-6)
- N-[(1E)-1-{N'-[(1Z)-(4-methylphenyl)methylidene]hydrazinecarbonyl}-2-[(4-methylpyrimidin-2-yl)amino]eth-1-en-1-yl]benzamide (CAS 306976-31-8)
- 4-(2,2,2-Trifluoroethoxy)pyridin-3-amine (CAS 1039822-70-2)
- 2-Butyl-5-methylfuran (CAS 3857-27-0)
- Neuroendocrine Regulatory Peptide-4 (human, mouse, rat) (H-7266.1000) (CAS 922704-18-5)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com